Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,990
Total Claims
$840K
Drug Cost
372
Beneficiaries
$2,258
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+111%
Cost per patient vs peers
$2,258 vs $1,068 avg
+62%
Brand preference vs peers
14.6% vs 9.0% avg
Brand vs Generic
Brand: 1,736 claims · $558K
Generic: 10,136 claims · $271K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 407 | $125K |
| Rivaroxaban | 143 | $42K |
| Empagliflozin | 128 | $40K |
| Semaglutide | 22 | $24K |
| Fluticasone Propion/Salmeterol | 45 | $20K |
| Insulin Aspart | 55 | $20K |
| Ipratropium/Albuterol Sulfate | 30 | $15K |
| Insulin Detemir | 48 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 63 | $14K |
| Dulaglutide | 17 | $14K |
| Mirabegron | 59 | $13K |
| Lipase/Protease/Amylase | 40 | $13K |
| Insulin Detemir | 36 | $12K |
| Fluticasone/Vilanterol | 26 | $11K |
| Pen Needle,dual Safety,diabetc | 114 | $11K |
Prescribing Profile
Patient Profile
76
Avg Age
59%
Female
2.46
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data